New: osimertinib

mrmedpharmacy (34)in tagrisso • 2 years ago
Use of Protein Kinase Inhibitors in the Treatment of NSCLC
Non-small cell lung cancer (NSCLC) is a type of lung cancer that accounts for about 85-90% of all cases of lung cancer. It can be difficult to treat, and often requires aggressive treatment. One of…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$0.00
0

Use of Protein Kinase Inhibitors in the Treatment of NSCLC